COLL Overview
Upcoming Projects (COLL)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (COLL)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (COLL)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (COLL)
-
Collegium (COLL) Announces Xtampza ER for Chronic Low Back Pain Scientific Presentations at PAINWeek 2017 Meeting
Ticker: COLL
Occurred on: Sep 07, 2017 -
Collegium Licenses the U.S. rights to ONSOLIS from BioDelivery Sciences
Ticker: COLL
Occurred on: May 11, 2016 -
Collegium Announces Issuance of U.S. Patent Covering DETERx, an Abuse-Deterrent, Extended-Release Technology Platform
Ticker: COLL
Occurred on: Feb 04, 2016
Strategic Initiatives (COLL)
-
Assertio Therapeutics (ASRT) Announces Closing of Sale of NUCYNTA Franchise to Collegium Pharmaceutical (COLL) for $375.0 Million
Tickers: ASRT, COLL
Announcement Date: Feb 13, 2020
